Alexander W. Teass, Ph.D., Raymond E. Biagini, Ph.D., D. Gayle DeBord, Ph.D., NIOSH/DBBS, and R. DeLon Hull, Ph.D., NIOSH/DSHEFS

Biographical details

Alexander W. Teass, Ph.D., Raymond E. Biagini, Ph.D., D. Gayle DeBord, Ph.D., NIOSH/DBBS, and R. DeLon Hull, Ph.D., NIOSH/DSHEFS Chapter F (1994)

Biological monitoring of exposure. A biomarker of exposure represents uptake of the agent through all routes of exposure. Thus, compared to air monitoring, biological monitoring offers a better estimate of the health risk in situations where routes of exposure other than inhalation are significant.
Source: Wikisource

Alexander W. Teass, Ph.D., Raymond E. Biagini, Ph.D., D. Gayle DeBord, Ph.D., NIOSH/DBBS, and R. DeLon Hull, Ph.D., NIOSH/DSHEFS Chapter F (1994)

Biological monitoring has the potential to assess worker exposure to industrial chemicals by all routes, including inhalation, skin absorption, and ingestion. Selection of an appropriate biomarker for an exposure requires knowledge of the distribution, metabolism, and excretion of the toxicant sufficient for selection of the proper compound to be determined, biological medium to be sampled, and time for obtaining a specimen. Often, most of the toxicological and pharmacological information available is from experimental animals and, thus, not always directly applicable to humans.
Source: Wikisource

Get perspective with Kwize: daily news enlightened by great literature